Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionSeries A Preferred Stock · Derivative | 41,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · derivative · entry 12 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 41,016 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F1 · derivative.exercise_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F1 · derivative.expiration_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F2 · ownership.nature: Lawrence M. Blatt Living Trust dated 8/27/14. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionCommon Stock | 1,452 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · nonDerivative · entry 11 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 18,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · ownership.nature: Zoe Anne Blatt Irrevocable Trust dated 8/24/14. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionCommon Stock | 1,452 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · nonDerivative · entry 10 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 18,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F4 · ownership.nature: Zachary David Blatt Irrevocable Trust dated 8/24/14. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionCommon Stock | 21,695 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · nonDerivative · entry 9 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 113,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F2 · ownership.nature: Lawrence M. Blatt Living Trust dated 8/27/14. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionCommon Stock | 3,394 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · nonDerivative · entry 8 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 17,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · ownership.nature: Zoe Anne Blatt Irrevocable Trust dated 8/24/14. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionCommon Stock | 3,394 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · nonDerivative · entry 7 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 17,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F4 · ownership.nature: Zachary David Blatt Irrevocable Trust dated 8/24/14. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionCommon Stock | 50,712 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · nonDerivative · entry 6 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 91,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F2 · ownership.nature: Lawrence M. Blatt Living Trust dated 8/27/14. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionCommon Stock | 13,671 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · nonDerivative · entry 5 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · ownership.nature: Zoe Anne Blatt Irrevocable Trust dated 8/24/14. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionCommon Stock | 13,671 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · nonDerivative · entry 4 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F4 · ownership.nature: Zachary David Blatt Irrevocable Trust dated 8/24/14. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionCommon Stock | 122,601 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · nonDerivative · entry 3 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 122,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F3 · ownership.nature: PENSCO Trust Company LLC Custodian FBO Dr. Lawrence Blatt IRA Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:55 UTC |
BLATT LAWRENCEChief Executive Officer
|
ConversionCommon Stock | 41,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018001 · doc1.xml · nonDerivative · entry 2 BLATT LAWRENCE · CIK 0001242110 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 41,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F2 · ownership.nature: Lawrence M. Blatt Living Trust dated 8/27/14. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionSeries B-2 Preferred Stock · Derivative | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · derivative · entry 23 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.exercise_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.expiration_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F8 · ownership.nature: Victor Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionSeries B-2 Preferred Stock · Derivative | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · derivative · entry 22 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.exercise_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.expiration_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F7 · ownership.nature: Dina Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionSeries B-2 Preferred Stock · Derivative | 21,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · derivative · entry 21 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 21,724 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.exercise_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.expiration_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F6 · ownership.nature: Beigelman and Lozovsky Living Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionSeries B-1 Preferred Stock · Derivative | 3,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · derivative · entry 20 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 3,359 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.exercise_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.expiration_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F8 · ownership.nature: Victor Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionSeries B-1 Preferred Stock · Derivative | 3,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · derivative · entry 19 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 3,359 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.exercise_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.expiration_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F7 · ownership.nature: Dina Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionSeries B-1 Preferred Stock · Derivative | 50,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · derivative · entry 18 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 50,781 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.exercise_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.expiration_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F6 · ownership.nature: Beigelman and Lozovsky Living Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionSeries A Preferred Stock · Derivative | 13,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · derivative · entry 17 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 13,559 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.exercise_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.expiration_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F8 · ownership.nature: Victor Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionSeries A Preferred Stock · Derivative | 13,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · derivative · entry 16 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 13,559 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.exercise_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.expiration_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F7 · ownership.nature: Dina Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionSeries A Preferred Stock · Derivative | 163,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · derivative · entry 15 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 163,842 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.exercise_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F5 · derivative.expiration_date: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F6 · ownership.nature: Beigelman and Lozovsky Living Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionCommon Stock | 1,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · nonDerivative · entry 14 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 18,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F8 · ownership.nature: Victor Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionCommon Stock | 1,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · nonDerivative · entry 13 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 18,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F7 · ownership.nature: Dina Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionCommon Stock | 21,724 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · nonDerivative · entry 12 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 236,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F6 · ownership.nature: Beigelman and Lozovsky Living Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionCommon Stock | 3,359 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · nonDerivative · entry 11 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 16,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F8 · ownership.nature: Victor Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionCommon Stock | 3,359 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · nonDerivative · entry 10 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 16,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F7 · ownership.nature: Dina Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionCommon Stock | 50,781 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · nonDerivative · entry 9 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 214,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F6 · ownership.nature: Beigelman and Lozovsky Living Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionCommon Stock | 13,559 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · nonDerivative · entry 8 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F8 · ownership.nature: Victor Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionCommon Stock | 13,559 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · nonDerivative · entry 7 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F7 · ownership.nature: Dina Beigelman Irrevocable Trust. Read SEC document |
| October 20, 2020 Filed Oct 20, 2020 20:53 UTC |
Beigelman LeonidDirector · President
|
ConversionCommon Stock | 163,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-018000 · doc1.xml · nonDerivative · entry 6 Beigelman Leonid · CIK 0001824721 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 163,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date. F6 · ownership.nature: Beigelman and Lozovsky Living Trust. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:12 UTC | ConversionSeries B-2 convertible Preferred Stock · Derivative | 571,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-055562 · doc4.xml · derivative · entry 4 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · CIK 0001787092 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 571,143 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of series B-1 convertible preferred stock and series B-2 convertible preferred stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.exercise_date: The shares of series B-1 convertible preferred stock and series B-2 convertible preferred stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.expiration_date: The shares of series B-1 convertible preferred stock and series B-2 convertible preferred stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. Read SEC document |
|
| October 20, 2020 Filed Oct 22, 2020 20:12 UTC | ConversionSeries B-1 convertible Preferred Stock · Derivative | 1,335,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-055562 · doc4.xml · derivative · entry 3 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · CIK 0001787092 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,335,048 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of series B-1 convertible preferred stock and series B-2 convertible preferred stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.exercise_date: The shares of series B-1 convertible preferred stock and series B-2 convertible preferred stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.expiration_date: The shares of series B-1 convertible preferred stock and series B-2 convertible preferred stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. Read SEC document |
|
| October 20, 2020 Filed Oct 22, 2020 20:12 UTC | ConversionCommon Stock | 571,143 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-055562 · doc4.xml · nonDerivative · entry 2 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · CIK 0001787092 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,906,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of series B-1 convertible preferred stock and series B-2 convertible preferred stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. Read SEC document |
|
| October 20, 2020 Filed Oct 22, 2020 20:12 UTC | ConversionCommon Stock | 1,335,048 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-055562 · doc4.xml · nonDerivative · entry 1 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · CIK 0001787092 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,335,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of series B-1 convertible preferred stock and series B-2 convertible preferred stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. Read SEC document |
|
| October 20, 2020 Filed Oct 22, 2020 20:31 UTC |
NOVO HOLDINGS A/S10% owner
|
ConversionSERIES B -2 CONVERTIBLE PREFERRED STOCK · Derivative | 241,219 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-055572 · doc4.xml · derivative · entry 5 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 241,219 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. F1 · price: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:31 UTC |
NOVO HOLDINGS A/S10% owner
|
ConversionSERIES B -1 CONVERTIBLE PREFERRED STOCK · Derivative | 563,851 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-055572 · doc4.xml · derivative · entry 4 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 563,851 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. F1 · price: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:31 UTC |
NOVO HOLDINGS A/S10% owner
|
ConversionSERIES A CONVERTIBLE PREFERRED STOCK · Derivative | 1,609,493 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-055572 · doc4.xml · derivative · entry 3 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 1,609,493 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. F1 · price: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:31 UTC |
NOVO HOLDINGS A/S10% owner
|
PurchaseCOMMON STOCK | 200,000 | $15.00 | $3,000,000.00 |
DisclosureSEC source: 0001209191-20-055572 · doc4.xml · nonDerivative · entry 2 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,614,563 F2 · shares: Represents a purchase from the underwriters in the Issuer's initial public offering. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:31 UTC |
NOVO HOLDINGS A/S10% owner
|
ConversionCOMMON STOCK | 2,414,563 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-055572 · doc4.xml · nonDerivative · entry 1 Novo Holdings A/S · CIK 0001388325 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,414,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.